Model-Based Meta-Analysis (MBMA) at GSK: Real-World Impact on Strategy and Trials
GSK shares real-world case studies on how Model-Based Meta-Analysis (MBMA) supports dose selection, virtual control…
Certara2025 年 7 月 31 日
Recapping a record-breaking 2025 Krakow HTA Symposium
We cover the key takeaways from CERTAINTY 2025, including the power of Model-Informed Drug Development…
Simona Colucci2025 年 7 月 30 日
Optimizing Dosing and Regulatory Outcomes in Duchenne Muscular Dystrophy (DMD) Drug Development
Certara supported DMD drug development for Givinostat, helping Italfarmaco with pharmacometric and regulatory strategy.
Certara2025 年 7 月 29 日
MIDD Strategies for Preclinical and Clinical Translation: A Collaboration Between Clinical Pharmacologists and Modeling Disciplines
Learn how clinical pharmacologists and modeling experts collaborate to improve preclinical-to-clinical translation.
Certara2025 年 7 月 29 日
